# A Trial to Assess the Safety, Tolerability, and Pharmacokinetics of MDT-637 in Healthy Volunteers

> **NCT01355016** · PHASE1 · COMPLETED · sponsor: **MicroDose Therapeutx, Inc** · enrollment: 48 (estimated)

## Conditions studied

- Drug Safety
- Respiratory Syncytial Virus Infections

## Interventions

- **DRUG:** MDT-637

## Key facts

- **NCT ID:** NCT01355016
- **Lead sponsor:** MicroDose Therapeutx, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09
- **Primary completion:** 2011-11
- **Final completion:** 2011-11
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2012-04-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01355016

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01355016, "A Trial to Assess the Safety, Tolerability, and Pharmacokinetics of MDT-637 in Healthy Volunteers". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01355016. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*